Drug Profile
LY 231415
Alternative Names: Folic acid analog LY 231415-Eli LillyLatest Information Update: 30 Jul 2002
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 12 Apr 1999 New profile
- 12 Apr 1999 Phase-III clinical trials for Cancer in USA (Unknown route)